Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 1,872.7 | 1,490.55 | 1,273.59 | 1,024.04 |
yoy growth (%) | 25.63 | 17.03 | 24.36 | 16.12 |
Raw materials | -446.31 | -373.9 | -286.86 | -219.31 |
As % of sales | 23.83 | 25.08 | 22.52 | 21.41 |
Employee costs | -320.22 | -257.43 | -232.06 | -175.08 |
As % of sales | 17.09 | 17.27 | 18.22 | 17.09 |
Other costs | -595.94 | -451.83 | -426.85 | -373.97 |
As % of sales (Other Cost) | 31.82 | 30.31 | 33.51 | 36.51 |
Operating profit | 510.21 | 407.38 | 327.81 | 255.67 |
OPM | 27.24 | 27.33 | 25.73 | 24.96 |
Depreciation | -75.31 | -69.77 | -68 | -31.04 |
Interest expense | -28.52 | -14.82 | -14.66 | -0.81 |
Other income | 53.01 | 51.26 | 57.6 | 31.51 |
Profit before tax | 459.39 | 374.04 | 302.75 | 255.31 |
Taxes | -115.34 | -93.93 | -79.57 | -87.33 |
Tax rate | -25.1 | -25.11 | -26.28 | -34.2 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 344.05 | 280.1 | 223.18 | 167.98 |
Exceptional items | 0 | 0 | 0 | 0 |
Net profit | 344.05 | 280.1 | 223.18 | 167.98 |
yoy growth (%) | 22.82 | 25.5 | 32.85 | 10.16 |
NPM | 18.37 | 18.79 | 17.52 | 16.4 |
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.